Q1 FY27 Results: Revenue up 24%, PAT up 39% YoY
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.5 pts less than Nifty Microcap 250 and 5.3 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For Q1 FY27 (quarter ended 30 June 2026): Revenue from Operations rose to Rs 240.91 lakhs (vs Rs 194.32 lakhs in Q1 FY26), up 24%. PAT climbed to Rs 106.92 lakhs from Rs 77.07 lakhs, up 39%. Total income at Rs 253.17 lakhs. Basic EPS at Rs 15.74 vs Rs 11.34 earlier. Investments segment drove growth. Auditor issued an unqualified limited review report. No exceptional items reported.
Strong quarterly show with double-digit revenue and profit growth, clean audit opinion; positive read for shareholders.